Health Condition 1: F510- Insomnia not due to a substance orknown physiological condition
Conditions
Interventions
Intervention1: CARCINOSIN in insomnia cases: Doses: As required for patient
Frequency: As per need of patient
Route of administration: Oral
Duration: 6 months
Control Intervention1: Not applicable:
Sponsors
National Institute of Homoeopathy
Eligibility
Inclusion criteria
Inclusion criteria: Participant suffering from insomnia verified by DSM5 criteria Severity Clinical Insomnia Severity Index (ISI) score more than or equal to 14 (moderate to severe insomnia) participants aged 18 to 60 years, all sexes. Subjects of all socioeconomic status, all religions Ability to understand either Bengali, Hindi, and or English participants giving written consent to participate in this study Subjects who agree to undergo laboratory investigation whenever required
Exclusion criteria
Exclusion criteria: Participants with unstable psychiatric disorder like severe intellectual disability or autism with severe behavioral disturbances, substance-induced severe psychiatric disorders. Pregnant women and lactating women. Immune compromised state like HIV AIDS (low CD4 count), Cancer (hematologic or solid tumors) on active treatment, Chronic kidney failure (end-stage renal disease) Concurrent medications: Use of hypnotics, sedatives, or stimulants that may interfere with sleep assessment. Participants who has taken homoeopathic medicines for any chronic illness within 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the prevalence of selected symptoms of carcinosin in population that suffering from insomnia and improved by carcinosin ,assessment done through ISI [insomnia severity index].Timepoint: At baseline 3 months and 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the effectiveness of homoeopathic medicines in insomnia To evaluate the effectiveness of carcinosin or other indicative medicine on quality of life through ORIDL [Outcome Related to Impact on Daily Living].Timepoint: At baseline 3 months and 6 months | — |
Countries
India
Contacts
Public ContactDr PRATIMA PAL
National Institute of Homoeopathy
Outcome results
None listed